Growth stocks have put up an impressive performance in 2020, with many of them coming out of the depths of the initial Covid crisis to end the year higher. Growth is not one of the traditional risk factors, so what does Growth encompass and what makes some implementations perform better than the others?
This paper decomposes 196 US Growth Funds representing $1.8 trillion AUM across 86 fund houses through PremiaLab Pure Factors®. The analysis provides unique insights into Growth funds’ inner factor dynamics and return drivers.